We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$353B
AUM Growth
-$4.15B
Cap. Flow
+$16.5B
Cap. Flow %
4.67%
Top 10 Hldgs %
37.06%
Holding
5,710
New
439
Increased
1,449
Reduced
2,853
Closed
470

Sector Composition

Rank Sector Weight
1 Technology 17.59%
2 Financials 9.21%
3 Consumer Discretionary 7.33%
4 Healthcare 5.59%
5 Communication Services 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBJL icon
4826
Innovator US Equity Accelerated 9 Buffer ETF July
XBJL
$74.2M
$2K ﹤0.01%
+59
New +$2.03K
DJAN icon
4827
FT Vest US Equity Deep Buffer ETF January
DJAN
$474M
$1.97K ﹤0.01%
52
-3,954
-99% -$154K
IRS
4828
IRSA Inversiones y Representaciones
IRS
$1.29B
$1.91K ﹤0.01%
148
IRD
4829
Opus Genetics
IRD
$306M
$1.86K ﹤0.01%
+1,900
New +$2.12K
DTIL icon
4830
Precision BioSciences
DTIL
$180M
$1.83K ﹤0.01%
384
-2,486
-87% -$12.7K
PPH icon
4831
VanEck Pharmaceutical ETF
PPH
$959M
$1.82K ﹤0.01%
20
NNDM
4832
Nano Dimension
NNDM
$316M
$1.79K ﹤0.01%
1,126
-38,727
-97% -$87.7K
PVLA
4833
Palvella Therapeutics
PVLA
$1.99B
$1.76K ﹤0.01%
63
FIRY
4834
Firy Inc
FIRY
$148M
$1.74K ﹤0.01%
386
+384
+19,200% +$2.19K
IMVT icon
4835
PUT
Immunovant
IMVT
$7.93B
$1.71K ﹤0.01%
100
FXNC icon
4836
First National Corp
FXNC
$287M
$1.68K ﹤0.01%
75
-1,497
-95% -$35.8K
QMMM
4837
QMMM Holdings
QMMM
$1.65K ﹤0.01%
1,586
OTEX icon
4838
Open Text
OTEX
$6.15B
$1.64K ﹤0.01%
65
+51
+364% +$1.4K
NYXH
4839
Nyxoah
NYXH
$140M
$1.63K ﹤0.01%
+234
New +$2.38K
EMO
4840
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.03B
$1.59K ﹤0.01%
+32
New +$1.57K
CURI icon
4841
CuriosityStream
CURI
$145M
$1.58K ﹤0.01%
588
-12,884
-96% -$31.3K
GILT icon
4842
Gilat Satellite Networks
GILT
$834M
$1.57K ﹤0.01%
247
-934
-79% -$6.49K
EPSN icon
4843
Epsilon Energy
EPSN
$169M
$1.57K ﹤0.01%
222
-4,779
-96% -$31.2K
MGRM
4844
DELISTED
Monogram Orthopaedics
MGRM
$1.56K ﹤0.01%
531
-10,774
-95% -$28.5K
MYO icon
4845
Myomo
MYO
$39M
$1.54K ﹤0.01%
321
-7,025
-96% -$40K
SKYX icon
4846
SKYX Platforms
SKYX
$147M
$1.53K ﹤0.01%
1,340
-29,472
-96% -$43.8K
DAO
4847
Youdao
DAO
$2.03B
$1.53K ﹤0.01%
+200
New +$1.65K
PASG icon
4848
Passage Bio
PASG
$14.4M
$1.49K ﹤0.01%
211
-447
-68% -$4.83K
RMTI icon
4849
Rockwell Medical
RMTI
$28.4M
$1.42K ﹤0.01%
125
-2,760
-96% -$50.1K
BJAN icon
4850
Innovator US Equity Buffer ETF January
BJAN
$345M
$1.4K ﹤0.01%
30
-761
-96% -$36.6K

Similar funds

Barclays's Q1 2025 Portfolio in Review

As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.

  • Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
  • Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
  • Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
  • Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
  • Barclays opened 439 new positions and closed 470 in Q1 2025.
  • Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.